Eric Venker, M.D.
Board Member
Immunovant, Inc. (IMVT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Eric Venker, M.D.
Eric Venker, M.D. is recorded as CEO and Board Member at Immunovant, Inc. (IMVT). Immunovant, Inc. reported in an 8-K filed April 21, 2025 that Eric Venker, M.D. was appointed Chief Executive Officer and principal executive officer, effective April 21, 2025.
“On April 18, 2025, upon the recommendation of the Nominating Committee, the Board appointed Eric Venker, M.D. as Chief Executive Officer and principal executive officer of the Company, effective April 21, 2025 (the "Start Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-04-21–present
-
Current
2021-09-09–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Immunovant, Inc.
Other people whose current roles at this company are on record from its filings.
- Eric Venker CEO
- Eric Venker, M.D., Pharm.D. CEO
- Dr. Frank M. Torti Chairman
- Renee Barnett CFO
- Tiago Girao CFO
- Melanie Gloria COO
- Jay S. Stout CTO
- W. Bradford Middlekauff General Counsel
- Andrew Fromkin Board Member
- Atul Pande, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.